STOCK TITAN

Pure Bioscience Inc - PURE STOCK NEWS

Welcome to our dedicated news page for Pure Bioscience (Ticker: PURE), a resource for investors and traders seeking the latest updates and insights on Pure Bioscience.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Pure Bioscience's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Pure Bioscience's position in the market.

Rhea-AI Summary
PURE Bioscience reports financial results for the fiscal second quarter, highlighting net product sales, net loss, and business developments. Despite a decrease in sales, the company aims to expand its footprint in the food industry through brand advertising, trade shows, distributor focus, and continued innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
earnings
-
Rhea-AI Summary
PURE Bioscience, Inc. (PURE) reported fiscal first quarter financial results, with net product sales of $718,000, a net loss of $735,000, and a net loss per share of ($0.01). The company's sales initiatives are paying off, with increased revenue and a customer-focused approach. The team is leveraging decades of combined experience and working on innovative solutions to enhance sanitation processes using IoT, SaaS, and automation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.25%
Tags
earnings
-
Rhea-AI Summary
PURE Bioscience reports financial results for fiscal year 2023, with net product sales of $1,871,000 and a net loss of ($4.0 million). Customer acceptance of SDC solutions in the food processing industry has increased, and the company has developed new applications for PURE Hard Surface. The company has attended conferences and trade shows to increase brand awareness and is working on marketing materials and website modifications. The CEO sees the increase in Q4 revenue as a turning point for the company. PURE has transitioned to an all-remote work environment since 2019.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-30.77%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.14%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.25%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.52%
Tags
earnings
Pure Bioscience Inc

OTC:PURE

PURE Rankings

PURE Stock Data

11.07M
66.61M
40.45%
1.82%
Toilet Preparation Manufacturing
Manufacturing
Link
United States
Rancho Cucamonga

About PURE

pure bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges. pure's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate (sdc)- based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green"​ products while providing competitive advantages in efficacy and safety. patented sdc is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. as a platform technology, sdc is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. pure is headquartered in el cajon, california (san diego metropolitan area). additional information on pure is available at www.purebio.com.